{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:55:21Z","timestamp":1790042121969,"version":"4.0.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Natural killer (NK) cells are a heterogeneous population of innate lymphocytes whose potent anticancer properties make them ideal candidates for cellular therapeutic application. However, our lack of understanding of the role of NK cell diversity in antitumor responses has hindered advances in this area. In this study, we describe a new CD56dim NK cell subset characterized by the lack of expression of DNAX accessory molecule-1 (DNAM-1). Compared with CD56bright and CD56dimDNAM-1pos NK cell subsets, CD56dimDNAM-1neg NK cells displayed reduced motility, poor proliferation, lower production of interferon-\u03b3, and limited killing capacities. Soluble factors secreted by CD56dimDNAM-1neg NK cells impaired CD56dimDNAM-1pos NK cell\u2013mediated killing, indicating a potential inhibitory role for the CD56dimDNAM-1neg NK cell subset. Transcriptome analysis revealed that CD56dimDNAM-1neg NK cells constitute a new mature NK cell subset with a specific gene signature. Upon in vitro cytokine stimulation, CD56dimDNAM-1neg NK cells were found to differentiate from CD56dimDNAM-1pos NK cells. Finally, we report a dysregulation of NK cell subsets in the blood of patients diagnosed with Hodgkin lymphoma and diffuse large B-cell lymphoma, characterized by decreased CD56dimDNAM-1pos\/CD56dimDNAM-1neg NK cell ratios and reduced cytotoxic activity of CD56dimDNAM-1pos NK cells. Altogether, our data offer a better understanding of human peripheral blood NK cell populations and have important clinical implications for the design of NK cell\u2013targeting therapies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018030676","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T20:45:24Z","timestamp":1559767524000},"page":"1681-1694","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions"],"prefix":"10.1182","volume":"3","author":[{"given":"Kimberley A.","family":"Stannard","sequence":"first","affiliation":[{"name":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lemoine","sequence":"additional","affiliation":[{"name":"INEM\u2013Institut Necker Enfants Malades, INSERM U1151, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Waterhouse","sequence":"additional","affiliation":[{"name":"Flow Cytometry and Imaging, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vari","sequence":"additional","affiliation":[{"name":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia;"},{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Chatenoud","sequence":"additional","affiliation":[{"name":"INEM\u2013Institut Necker Enfants Malades, INSERM U1151, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-5393","authenticated-orcid":false,"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Martinet","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Toulouse, INSERM Unit\u00e9 Mixte de Recherche 1037, Toulouse, France;"},{"name":"Institut Universitaire du Cancer, Toulouse, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-7240","authenticated-orcid":false,"given":"Mark J.","family":"Smyth","sequence":"additional","affiliation":[{"name":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia;"},{"name":"School of Medicine, The University of Queensland, Herston, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-2432","authenticated-orcid":false,"given":"Camille","family":"Guillerey","sequence":"additional","affiliation":[{"name":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia;"},{"name":"School of Medicine, The University of Queensland, Herston, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"issue":"5","key":"2020021108303790800_B1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"issue":"15","key":"2020021108303790800_B2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S1286-4579(02)00037-0","article-title":"Human NK cells and their receptors","volume":"4","author":"Moretta","year":"2002","journal-title":"Microbes Infect"},{"issue":"11","key":"2020021108303790800_B3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"2020021108303790800_B4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2016.00262","article-title":"Human circulating and tissue-resident CD56(bright) natural killer cell populations","volume":"7","author":"Melsen","year":"2016","journal-title":"Front Immunol"},{"issue":"8","key":"2020021108303790800_B5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","article-title":"Human NK cell receptors\/markers: a tool to analyze NK cell development, subsets and function","volume":"83","author":"Montaldo","year":"2013","journal-title":"Cytometry A"},{"issue":"1","key":"2020021108303790800_B6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J Exp Med"},{"issue":"8","key":"2020021108303790800_B7","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","article-title":"CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation","volume":"178","author":"Romagnani","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"2020021108303790800_B8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"issue":"208","key":"2020021108303790800_B9","doi-asserted-by":"crossref","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","article-title":"Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry","volume":"5","author":"Horowitz","year":"2013","journal-title":"Sci Transl Med"},{"issue":"5","key":"2020021108303790800_B10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","article-title":"High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice","volume":"49","author":"Crinier","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"2020021108303790800_B11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/icb.2013.95","article-title":"DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins","volume":"92","author":"de Andrade","year":"2014","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"2020021108303790800_B12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni.2850","article-title":"The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions","volume":"15","author":"Chan","year":"2014","journal-title":"Nat Immunol"},{"issue":"24","key":"2020021108303790800_B13","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1158\/0008-5472.CAN-04-2682","article-title":"Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction","volume":"64","author":"Castriconi","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"2020021108303790800_B14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"issue":"13","key":"2020021108303790800_B15","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1182\/blood-2012-08-449025","article-title":"ATM-dependent spontaneous regression of early E\u03bc-myc-induced murine B-cell leukemia depends on natural killer and T cells","volume":"121","author":"Croxford","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2020021108303790800_B16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI77181","article-title":"Immunosurveillance and therapy of multiple myeloma are CD226 dependent [published correction appears in J Clin Invest. 2015;125(7):2904]","volume":"125","author":"Guillerey","year":"2015","journal-title":"J Clin Invest"},{"issue":"2","key":"2020021108303790800_B17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4049\/jimmunol.0903225","article-title":"DNAM-1\/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases","volume":"184","author":"Chan","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"2020021108303790800_B18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2013.12.011","article-title":"Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection","volume":"40","author":"Nabekura","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"2020021108303790800_B19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood-2010-08-301374","article-title":"NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies","volume":"117","author":"Magri","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2020021108303790800_B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.celrep.2015.03.006","article-title":"DNAM-1 expression marks an alternative program of NK cell maturation","volume":"11","author":"Martinet","year":"2015","journal-title":"Cell Reports"},{"issue":"1","key":"2020021108303790800_B21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4049\/jimmunol.1502603","article-title":"Human lymphoid tissues harbor a distinct CD69+CXCR6+ NK cell population","volume":"197","author":"Lugthart","year":"2016","journal-title":"J Immunol"},{"issue":"9","key":"2020021108303790800_B22","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J Clin Invest"},{"issue":"8","key":"2020021108303790800_B23","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J Immunol"},{"issue":"41","key":"2020021108303790800_B24","doi-asserted-by":"crossref","first-page":"66586","DOI":"10.18632\/oncotarget.11953","article-title":"Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"2020021108303790800_B25","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1158\/0008-5472.CAN-06-4230","article-title":"The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells","volume":"67","author":"El-Sherbiny","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"2020021108303790800_B26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/icb.2011.15","article-title":"Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients","volume":"90","author":"Sanchez-Correa","year":"2012","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"2020021108303790800_B27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"issue":"5","key":"2020021108303790800_B28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80136-3","article-title":"Physical and functional association of LFA-1 with DNAM-1 adhesion molecule","volume":"11","author":"Shibuya","year":"1999","journal-title":"Immunity"},{"issue":"12","key":"2020021108303790800_B29","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.4049\/jimmunol.1100330","article-title":"CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation","volume":"186","author":"B\u00e9ziat","year":"2011","journal-title":"J Immunol"},{"issue":"415","key":"2020021108303790800_B30","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"issue":"11","key":"2020021108303790800_B31","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","article-title":"Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4","volume":"60","author":"Holt","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"2020021108303790800_B32","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.4049\/jimmunol.0803036","article-title":"Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15","volume":"182","author":"Haraguchi","year":"2009","journal-title":"J Immunol"},{"issue":"10","key":"2020021108303790800_B33","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.145.10.3194","article-title":"Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis","volume":"145","author":"Robertson","year":"1990","journal-title":"J Immunol"},{"issue":"7","key":"2020021108303790800_B34","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"issue":"19","key":"2020021108303790800_B35","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2020021108303790800_B36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1084\/jem.161.6.1464","article-title":"A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562","volume":"161","author":"Phillips","year":"1985","journal-title":"J Exp Med"},{"key":"2020021108303790800_B37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front Immunol"},{"issue":"7","key":"2020021108303790800_B38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20051143","article-title":"Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells","volume":"202","author":"Bryceson","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"2020021108303790800_B39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.182.2.948","article-title":"A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells","volume":"182","author":"Mace","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"2020021108303790800_B40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.leu.2404499","article-title":"CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases","volume":"21","author":"Grzywacz","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"2020021108303790800_B41","doi-asserted-by":"crossref","first-page":"e31959","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"issue":"35","key":"2020021108303790800_B42","doi-asserted-by":"crossref","first-page":"14584","DOI":"10.1073\/pnas.1112188108","article-title":"Mobilization of natural killer cells inhibits development of collagen-induced arthritis","volume":"108","author":"Leavenworth","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2020021108303790800_B43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin Immunol"},{"issue":"6","key":"2020021108303790800_B44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bcp.2010.05.002","article-title":"PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling","volume":"80","author":"Martinet","year":"2010","journal-title":"Biochem Pharmacol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/11\/1681\/1631940\/advances030676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/11\/1681\/1631940\/advances030676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:48:31Z","timestamp":1694933311000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/11\/1681\/246708\/Human-peripheral-blood-DNAM1neg-NK-cells-are-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018030676","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}